Amedisys (AMED) PT Raised to $60 at Baird Following 3Q
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Benchmark Downgrades Amedisys (AMED) to Hold
November 9, 2017 9:28 AM ESTBenchmark downgraded Amedisys (NASDAQ: AMED) from Buy to Hold.
For an analyst ratings summary and ratings history on Amedisys click here. For more ratings news on Amedisys click here.
Shares of Amedisys closed at $58.49 yesterday.
... MoreAmedisys (AMED) PT Raised to $64 at Jefferies
November 8, 2017 8:35 AM ESTJefferies raised its price target on Amedisys (NASDAQ: AMED) to $64.00 (from $60.00) while maintaining a Buy rating following Q3.
Analyst Brian Tanquilut said the 5% SS increase in Medicare episodes highlights early traction the company is seeing with its revamped sales force and growth initiatives.
... More